Modern aspect of the approach to diagnostics and treatment of locally advanced malignant head and neck (literature review)
Abstract
In connection with the rapid development of new diagnostic and therapeutic technologies, locally advanced (MR) forms of malignant neoplasms of the head and neck (MNOGN) stages III–IV are still one of the most urgent and unsolved problem of clinical ocology. The article provides an overview of the available literature in bibliographic databases, which testifies to the continuing trend of an increase in the incidence of malignant tumors of the head and neck.
As it turned out, there are currently few data devoted to the study of the role of chemoebolization of malignant tumors of the head and neck. However, almost all of these authors believe that superselective endovasal chemoembolization of a tumor in patients with MNOHS can lead to a significant improvement in their quality of treatment and life. An additional study of the problem was carried out according to the references of the found articles.
About the Authors
S. D. Radzhabov
Russian Research Neurosurgical Institute named after V.I. prof. A. L. Polenova – branch of the «National Medical Research Center named after V. A. Almazov «Ministry of Health of Russia
Russian Federation
Russian Federation
St. Petersburg
A. A. Ivanov
Russian Research Neurosurgical Institute named after V.I. prof. A. L. Polenova – branch of the «National Medical Research Center named after V. A. Almazov «Ministry of Health of Russia
Russian Federation
Russian Federation
St. Petersburg
V. G. Voronov
Russian Research Neurosurgical Institute named after V.I. prof. A. L. Polenova – branch of the «National Medical Research Center named after V. A. Almazov «Ministry of Health of Russia
Russian Federation
Russian Federation
St. Petersburg
References
1. Vikhlyanov I. V., Lazarev A.F., Shoikhet YA.N. i dr. Kompleksnoe leche-nie opukholei orofaringeal’noi zony // Vestnik RONTS im. H.H. Blokhina RAMN.– 2006. – T. 17.– № 4. – S. 24–27 (In Russ.).
2. Davydov M.I., Aksel› E.M. Statistika zlokachestvennykh novoobra-zovanii v Rossii i stranakh SNG v 2005 g. // Vestnik Rossiiskogo onkologIcheskogo nauchnogo tsentra imeni H.H. Blokhina.– 2007. – T. 18 (prilozhenie 1). (In Russ.).
3. Kaprin A.D. Zlokac hestvennye novoobrazovaniya v Rossii v 2013 godu (zabolevaemost’ i smertnost’) /A.D.Kaprin, V. V. Starinskii, G. V. Petrova. Moskva, 2015.– 250 s (In Russ.).
4. Konstantinova YU.S. Ehffektivnost› khimioehmbolizatsii vetvei naruzhnoi sonnoi arterii u patsientov s mestno-rasprostranennym ploskoklntochnym rakom govy i sheii. Avtoreferat kan. med. nauk. Voronezh. 2017. 25 s. (In Russ.).
5. Matyakin E. G., Parshikova S.M. Prognosticheskoe znachenie nekotOrykh klinicheskikh i morfologicheskikh priznakov regionarnykh metastazov rAka yazyka // Vest. VONTS AMN SSSR.– 1990.– № 2. – S. 33–35 (In Russ.).
6. Paches A.I. Opukholi golovy i shei. – M.: Meditsina, 2001. – S. 379421(In Russ.).
7. Paches A.I. Opukholi golovy i shei: ruk-vo /A.I.Paches. 5 izd. dop., i pererab. – Moskva: Prakticheskaya meditsina, 2013. –478 s. (In Russ.)
8. Petrova G. V., Starinskii V. V., Kharchenko V. V., Gretsova N. V. Sostoya-nie diagnostiki zlokachestvennykh novoobrazovanii v Rossii v 2008 godu // Materialy VII s”ezda onkologov Rosii.– 2009. – S. 32. (In Russ.).
9. Skurenko V. P. Obosnovanie vybora luchevoi i khimioluchevoi terapii bol’nykh mestno-rasprostranennym rakom rotoglotki i polosti rta III–IV stadii. dis. …d-ra med. nauk/ V. P. Skurenko. Sankt-Peterburg, 2010.-237 s. (In Russ.).
10. Taneeva A.SH., Matyakin E. G., Azizyan R.I. s soavt. Kombinirovannye rekonstruktivnye operatsii prirasprostranennykh opukholyakh orofaringEal’noi zony // Sovremennaya onkologiya.– 2002. – T. 4.– № 3. – S. 124–126. (In Russ.).
11. Tarazov P. G. Metody regionarnoi terapii opukholei razlichnykh lokalizatsii / P. G. Tarazov // Prakticheskaya onkologiya. Tom 16. № 4.– 2015. –S131–139. (In Russ.).
12. Chissov V.I., Starinskii V. V., Petrova G. V. Zlokachestvennye novo-obrazovaniya v Rossii v 2006 godu (zabolevaemost’ i smertnost’). – M., 2008. (In Russ.).
13. Chuksina T.YU., Teplov S.N., Yaitsev S. V. Pokazateli kletochnogo, gu-moral’nogo i mukozal’nogo kompartmentov immunnoi sistemy u bol’nykh rakom polosti rta // Sibirskii onkologicheskii zhurnal.– 2008.– № 1. – S. 34–36. (In Russ.).
14. Ang K.K., Harris J., Garden A.S. et al. Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99–14 // J. Clin. Oncol.– 2005. – V. 23.– № 13.-P. 3008–3015.
15. Bernier J., Bataini J. P. Regional outcome in oropharingeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases // Radiother. Oncol.– 1986. – Vol.6. – P.– 87–103.
16. Bernier J., Coens C., Remenar E. et al. Impact on quality of life (QoL) of the addition of docetaxel (T) to neoadjuvant cisplatin plus 5-fluorouracil treatment in patients with locally advanced unresectable squamous cell carcinoma of the head and neck (SCCHN): EORTC study 24971 // J. Clin. Oncol.– 2006. – Vol. 24. – P. 285s.
17. Bertino G., Benazzo M., Gatti P. et al. Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: Single-centre five-years results // BCM Cancer.– 2007. – Vol. 7. – P. 62–70.
18. Carvalho A.L., Magrin J., Kowalski L. P. et al. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach // Oral. Dis.– 2003.-Vol. 9.-P. 109–111.
19. Colevas A.D., Norris C.M., Tishler R.B. et al. Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leuvorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN) // Am. J. Clin. Oncol.– 2002. – Vol. 25. – P. 153–159.
20. Corvo R., Benasso M., Sanguined G. et al. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck // Cancer.– 2001. – Vol. 92. – P. 2856–2867.
21. Cox J.D., Padak T.F., Marcial V. A. et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of Radiation Therapy Group Protocol 8313 // Int. J. Radiat. Oncol. Biol. Phys.– 1990. – Vol. 18.– № 3. – P. 515–521.
22. De Andres L., Brunet J., Lopez-Pousa A. et al. Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV–Mo head and neck cancer // J. Clin. Oncol.– 1995. – Vol. 13. – P. 1493–1500.
23. DeNittis A.S., Machtay M., Rosenthal D.I. et al. Advanced resectable oropharingeal carcinoma treated with surgery and postoperative radiotherapy: Oncologic outcome and functional assessment // Am. J. Otolaryngol.– 2001. – Vol. 22. – P. 329–335.
24. Depondt J., Gehanno., Martin M. et al. Neoadjuvant chemotherapy with Carboplatin/5-fluorouracil in head and neck cancer // Oncology.– 1993. – Vol. 50. Suppl. 2. – P. 23–27.
25. Dobrowsky W., Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin С in head and neck cancer // Radiother. Oncol.2000. – V. 57. – P. 119–124.
26. Domenge С., Hill С., Lefebvre J. L. et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d’Etude des Tumeurs des Teteur de la tete e du cou (GETTEC) // Br. J. Cancer.– 2000. – Vol. 83.№ 12.-P. 1594–1598.
27. Eisbruch A., Schwartz M., Rasch С. et al. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: Which anatomic structures are affected and can they be spared by IMRT? // Int. J. Radiat. Biol. Phys.– 2004. – Vol. 60.-P. 1425–1439.
28. Furutani K., Fuwa N., Kodaira T. et al. Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base // Oral. Oncol.– 2002. – Vol. 38. – P. 145–152.
29. Fuwa N., Ito Y., Matsumoto A. et al. A combination therapy of continuous superselective intra-arterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma // Cancer.– 2000. – Vol. 89.– № 10. – P. 2099–3105.
30. Fuwa N., Kodaira T., Furutani K. et al. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin and intraarterial infusion carboplatin for locally advanced head and neck cancer – Phase II study // Oral. Oncol.– 2007. – Vol.43. – P. 1014–1020.
31. Fuwa N., Kodaira T., Furutani K. et al. Intra-arterial chemoradiotherapy for, locally advanced oral cavity cancer: Analysis of therapeutic results in 134 cases // Br. J. Cancer.– 2008. – Vol. 98. – P. 1039–1045.
32. Garden A.S., Harris J., Vokes E. E. et al. Preliminary Results of Radiation Therapy Oncology Group 97–03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck // J. Clin. Oncol.– 2004. – Vol. 22.– № 14. – P. 2856–2864.
33. Gourin C.G., Johnson J.T. Surgical treatment of squamous cell carcinoma of the base of tongue // Head Neck.– 2001. – Vol. 23. – P. 653–660.
34. Ikushima I., Kogori Y., Ishii A. et al. Superselective arterial infusion for squamous cell carcinomas of oral cavity: Histopathologic effects on metastasis neck lymph nodes // Eur. Arch. Otorhinolaryngol.– 2007. – Vol. 3. – P. 269–275.
35. Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2007. CA Cancer // J. Clin.– 2007. – Vol. 57. – P. 43–66.
36. Johnson C.R., Silverman L.B., Clay L.B. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck – is postradiotherapy neck dissection necessary? // Radiation Oncology Investigation.– 1998. – Vol. 6. – P. 52–57.
37. Kim K.B., Kliuri F.R., Shin D.M. Recent advances in the management of squamous cell carcinoma of the head and neck // Expert Rev. Anticancer Ther.– 2001. –Vol. l.-P. 100–110.
38. Kitagawa Y., Nishizawa S., Sano K. et al. Prospective comparison of I8F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intra-arterial chemotherapy and radiotherapy for head and neck carcinoma // J. Nucl. Med.– 2003. – Vol. 44. – P. 198–206.
39. Сovacs A.F., Grüterich G., Wagner M. Long-term complete remission of oral cancer after anti-neoplastic chemotherapy as single treatment modality: Role of local chemotherapy // J. Chemotherapy.– 2002. – Vol. 14. – P. 95–101.
40. Сovacs A.F. Intra-arterial chemotherapy and chemoembolization in head and neck cancer: Establishment as a neoadjuvant routine method // Cancer Ther.– 2003a. –Vol. l.-P. 1–9.
41. Сovacs A.F. Intra-arterial induction high-dose chemotherapy with cis-platin for oral and oropharyngeal cancer: Long-term result // Br. J. Cancer.– 2004. – Vol. 90.-P. 1323–1328.
42. Сovacs A.F. Chemoembolization using cisplatin crystal as neoadjuvant treatment of oral cancer // Cancer Biother. Radiopharm.– 2005. – Vol. 20. – P. 267–279.
43. Kim K.B., Kliuri F.R., Shin D.M. Recent advances in the management of squamous cell carcinoma of the head and neck // Expert Rev. Anticancer Ther.– 2001. –Vol. l.-P. 100–110.
44. Lefebvre J.L., Lantigau E., Kara A. et al. Oral cavity, pharynx and larynx cancer // Prognostic factors in cancer (2nd ed.)/ Gospodarowicz M. K. (editor). – New York: John Wiley and sons, 2001. – P. 151–166.
45. Licitra L., Locati L.D. Head and neck // Ann. Oncol.– 2004. – Vol. 15. – Suppl. 4. – P. 267–273.
46. Licitra L., Vermorken J.B. Is there still a role for neoadjuvant chemotherapy in head and neck cancer? // Ann. Oncol.– 2004. – Vol. 15. – P. 7–11.
47. Molinary R., Chiesa F., Cantu G. et al. Prognostic factors in cancer of the oral cavity and anterior oropharynx treated with preliminary neoadjuvant intraarterial chemotherapy followed by surgery // In: Eckardt A. (ed): Intra-arterial chemotherapy in Head and Neck Cancer – Current Result and Future Perspectives. – Reinbek: Einhorn-Presse Verlag.– 1999. – P. 148–161.
48. Morton R.P., Rugman F., Dorman E.B. et al. Cisplatin and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: A randomized factorial phase III controlled trial // Cancer Chemother. Pharmacol.– 1985. – Vol. 15.-P. 283–289.
49. Nakasato T., Katoh K., Sone M. et al. Superselective continuous arterial infusion chemotherapy through the superficial temporal artery for oral cavity tumors // Am. J. Neuroradiol.– 2000. – Vol. 21. – P. 1917–1922.
50. Nieder C. Andratsbke N.H. Combinations of cytotoxic drugs, ionizing radiation and a angiogenesis inhibitors // Multimodal concepts for integration of cytotoxic drugs. Ed. Brady L. W. et al., Springer, Heidelberg.– 2006. – P. 103114.
51. Nieder C., Gregoire V., Ang K.K. Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple? // Int. J. Radiat. Oncol. Biol. Phys.– 2001. – Vol. 50. – P. 727–733.
52. Nieder C., Lordick F. Combinations of platinum compounds and ionizing radiation // Multimodal concepts for integration of cytotoxic drugs. Ed. Brady L. W. et al. Springer, Heidelberg.– 2006. – P. 93–101.
53. Okamoto Y., Konno A., Togawa K. et al. Microcapsule chemoembolization for head and neck cancer // Eur. Arch. Oto-Rhino-Laryngol.– 1985. – Vol. 242.-P. 105–111.
54. Pivot X., Poissonnet G., Dassonville O. et al. Analysis of overall survival clinical prognostic factors for patients with locally recurrents or metastatic head and neck squamous cell carcinoma // Oncology.– 2001. – Vol. 61. – P. 197–204.
55. Rohde S., Kovacs B., Turowski B. et al. Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer // Am. J. Neuroradiol.– 2005. – V. 26. – P. 1804–1809.
56. Robbins K.T., Kumar P., Wong F.S.H. et al. Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients // Head Neck.– 2000. –V. 22.-P. 68–693.
57. Robbins K.T., Kumar P., Harris J. et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multiinstitutional setting: Results of Radiation Therapy. Oncology Group trial 9615 // J. Clin. Oncol.– 2005. – Vol. 23.– № 7. – P. 1447–1454.
58. Tegeder I., Brautigam L., Seegel M. et al. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer // Clin. Pharmacol. Ther.– 2003. – Vol. 73. – P. 417–426.
59. Tegeder I., Brautigam L., Seegel M. et al. Cisplatin tumor concentrations following IA cisplatin infusion or embolization in oral cancer patients // Clinical Parmacology & Therapeutics, in press.– 2008.
60. Trotti A. Toxicity in head cancers: A review of trends and issues // Int. J. Radiat. Oncol. Biol. Phys.– 2000. – Vol. 47. – P. 1–12.
61. Trotti A., Byhardt R., Stetz J. et al. Common Toxicity Criteria, Version 2.0: An improved reference for the grading of acute effects of cancer treatment: Impact on radiotherapy // Int. J. Radiat. Oncol. Biol. Phys.– 2000. – Vol. 47. – P. 3–47.
62. Trotti A., Bellm L. A., Epstein J.B. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review // Radiother. Oncol.– 2003. – Vol. 66. – P. 2–262.
63. Trotti A., Colevas A.D., Setser A. et al. CTCAE v 3,0: Development of a comprehensive grading system for the adverse effects of cancer treatment // Semin. Radat. Oncol.– 2003. – Vol. 13. – P. 176–181.
64. Trotti A., Bentzen S.M. The need for adverse effects reporting standards in oncology clinical trials // J. Clin. Oncol.– 2004. – Vol. 22.– № 1. – P. 19–22.
65. Trotti A. Long-term outcomes of RTOG 90–03: A comparison of hyper-fraction ation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma // Proc. Amer. Soc. Ther. Rad. One. (ASTRO), Denver, CO // Int. J. Radiat. Oncol. Biol. Phys. [63]. Suppl. Pg. S70-S71. – Abstr. 116.– 2005.
66. Trotti A., Pajak T., Gwede C. et al. The TAME Adverse Event Summary and Risk Classification System: Analysis of the RTOG Head and Neck Database. Proc. Am. Soc. Clin. Oncol. (ASCO), Orlano, FL, J. Clin. Oncol. [23] (16s). Pg. 534s. – Abstr. 6026.– 2005.•V-sV
67. Tsurumaru D., Kuroiwa T., Yabuuchi H. et al. Efficacy of intra-arterial infusion chemotherapy for head and neck cancer using coaxial catheter technique: Initial experience // Cardiovasc. Intervent. Radiol.– 2007. – Vol. 30. – P. 207–211.
68. Vermorken J.B. Medical treatment in head and neck // Ann. Oncol.– 2005. – Vol. 16. – Suppl. 2. – P. 258–264.
69. Vermorken J.B., Remenar E., Van Herpen C. et al. Standard cis-platin/ infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for unresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): A phase III trial of the EORTC Head and Neck Cancer Group (EORTC24971) // Program and abstracts of the 40th Annual Meeting of the American Society of Clinical Oncology; June 5–8, 2004; New Orleans, Louisiana. – Abst. 5508.
70. Wong S.J., Agha Z., Milligan S. Concurrent chemotherapy practice patterns for head and neck cancer: What is standard of care? // J. Clin. Oncol.– 2006 ASCO Ann. Meeting Proc. Part I. – Vol. 24.– № 18S, 2006. – Abstr. 5542.
71. Yamashita Y., Goto M., Katsuki T. Chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for oral cancer // Gan To Kagaku Ryoho.– 2002. – Vol. 29. – P. 905–909 (In Japanese).
Review
For citations:
Radzhabov S.D., Ivanov A.A., Voronov V.G. Modern aspect of the approach to diagnostics and treatment of locally advanced malignant head and neck (literature review). Russian Neurosurgical Journal named after Professor A. L. Polenov. 2021;13(3):79-84. (In Russ.)
Views:
45
Email this article 